Skip to main contentSkip to navigation
Sirius Investors

3341.T Stock: NIHON CHOUZAI Co.,Ltd. Stock Price, Analysis & Insights

Get live 3341.T stock price $3910.00, comprehensive NIHON CHOUZAI Co.,Ltd. stock analysis, charts, news, and expert forecast. Real-time 3341.T stock data and investment insights.

3910.00
0.38%Today
3341.TNIHON CHOUZAI Co.,Ltd. • Tokyo Stock Exchange • Healthcare
Market Cap
116.82B
Volume
55.80K
52W High
23773364200.00
52W Low
1314.00

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Nihon Chouzai Co., Ltd. is a Japanese enterprise primarily known for operating a vast network of health insurance-compliant dispensing pharmacies throughout the country. Beyond its core retail pharmacy business, the company develops and markets gener...

Company Information

CEO
Kazunori Ogi
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
5864

Contact Information

Address
GranTokyo North Tower
Country
JP

Investment Analysis & Business Insights

Healthcare
Medical - Pharmaceuticals

Investment Highlights

Market leader with 116.8 billion market capitalization

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 45.9)

Lower volatility stock (Beta: 0.41) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for NIHON CHOUZAI Co.,Ltd. shareholders
  • Market volatility can significantly impact stock price, especially for mid-cap stocks
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for NIHON CHOUZAI Co.,Ltd.
  • Investors should consider how NIHON CHOUZAI Co.,Ltd. fits within their overall portfolio allocation
  • Premium valuation (P/E: 45.9) requires strong growth to justify

Market Cap

116.82B

P/E Ratio (TTM)

45.91

Beta

0.41

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

43/100 ⭐⭐⭐

Overall
-1.0%
NYSE
-1.6%
NASDAQ
-0.4%
Sector1D1W1MP/EScore
Financial Services+0.3%+1.3%+1.9%19.8
83/100⭐⭐⭐⭐⭐
Technology+0.8%+1.1%+3.0%52.0
76/100⭐⭐⭐⭐⭐
Basic Materials+0.8%+0.3%+1.9%27.9
69/100⭐⭐⭐⭐
Industrials-0.3%-0.9%+2.7%43.0
64/100⭐⭐⭐⭐
Communication Services-0.8%-1.3%+0.4%21.9
48/100⭐⭐⭐
Consumer Defensive+0.6%+1.6%-2.5%31.2
44/100⭐⭐⭐
Healthcare-1.0%-2.0%+1.5%30.5
43/100⭐⭐⭐
Real Estate+0.5%-1.1%-0.0%50.0
33/100⭐⭐
Energy+0.5%-3.6%-0.0%35.9
31/100⭐⭐
Utilities+2.0%-1.3%-5.1%26.1
31/100⭐⭐
Consumer Cyclical-0.3%+0.3%-0.2%55.8
28/100⭐⭐

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-06-13.